Form 4: Arcadia Biosciences Director Albert D. Bolles Acquires Stock Options
SEC Form 4
Director Albert D. Bolles reports acquisition of stock options in Arcadia Biosciences.
Summary
- On August 19, 2024, Albert D. Bolles, a director of Arcadia Biosciences, Inc. (RKDA), acquired 10,909 stock options with an exercise price of $2.71.
- Following the transaction, Bolles directly owns 13,394 derivative securities.
- The options vest on the earlier of August 19, 2025, or the date of the Issuer's next Annual Meeting of Stockholders, contingent upon continued service.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director generally indicates confidence in the company's future, but it's a routine transaction.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting of the options is contingent upon continued service, suggesting an incentive for the director to remain with the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency regarding insider transactions, allowing investors to stay informed about the actions of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 08/19/2024 | Date of the stock option transaction. |
| 08/19/2025 | Date the options become 100% vested and exercisable, contingent upon continued service, or earlier if the next Annual Meeting of Stockholders occurs before this date. |
| 08/21/2024 | Date of signature on the Form 4 filing. |
Keywords
stock options, derivative securities, Form 4, Arcadia Biosciences, RKDA, director, Albert D. Bolles, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.